Comparing two eye procedures for keratoconus: cross-linking alone or with surface laser removal
Compares cross-linking alone with cross-linking plus laser treatment in adults with keratoconus.
Key facts
- Who runs it
- Oslo University Hospital
- Where
- Norway1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)
- Status
- Recruiting
- People taking part
- 81 people, planned
- Started
- 12 Feb 2024
- Expected to end
- 1 Feb 2034
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Corneal collagen cross linking (CXL)
- Transepithelial phototherapeutic keratectomy (t-PTK)
- Record updated
- 16 February 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with keratoconus that is getting worse and needs corneal cross-linking (CXL). It compares CXL alone with CXL combined with t-PTK, a laser treatment of the cornea surface.
- Age
- 18 years or older, no upper age limit
- Sex
- All sexes
- Disease stage
- Progressive keratoconus (a cone-shaped, thinning cornea that is getting worse) where CXL is needed
- Biomarker or test result
- Corneal thickness of at least 420 μm
Main reasons for not taking part
- Another eye disease that causes poor vision
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit
- Progressive keratoconus with indication for CXL
- Corneal thickness ≥ 420 μm
Who cannot take part
- Other eye disease causing visual impairment
This trial is currently available in Norway.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to compare CXL with combined treatment with CXL and t-PTK.
Read full original descriptionShow less
The main questions it aims to answer are whether combined treatment can give better visual acuity and if the treatments are equally safe.
The 2 groups in the trial
- CXLExisting treatment, for comparison
Treatment with CXL alone
Treatment: Corneal collagen cross linking (CXL)
- CXL and t-PTKTreatment being tested
Treatment with t-PTK combined with CXL
Treatment: Corneal collagen cross linking (CXL) and Transepithelial phototherapeutic keratectomy (t-PTK)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)
- Plain-language title
- Comparing two eye procedures for keratoconus: cross-linking alone or with surface laser removalGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 16 February 2024